Home
>
National Drug Code (NDC)
>
GAVISCON
GAVISCON - 0135-0095-41 - (aluminum hydroxide and magnesium carbonate)
Drug Information of GAVISCON
| Product NDC: | 0135-0095 |
| Proprietary Name: | GAVISCON |
| Non Proprietary Name: | aluminum hydroxide and magnesium carbonate |
| Active Ingredient(s): | 254; 237.5 mg/5mL; mg/5mL & nbsp; aluminum hydroxide and magnesium carbonate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of GAVISCON
| Product NDC: | 0135-0095 |
| Labeler Name: | GlaxoSmithKline Consumer Healthcare LP |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part331 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20110114 |
Package Information of GAVISCON
| Package NDC: | 0135-0095-41 |
| Package Description: | 355 mL in 1 BOTTLE (0135-0095-41) |
NDC Information of GAVISCON
| NDC Code | 0135-0095-41 |
| Proprietary Name | GAVISCON |
| Package Description | 355 mL in 1 BOTTLE (0135-0095-41) |
| Product NDC | 0135-0095 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | aluminum hydroxide and magnesium carbonate |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 20110114 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | GlaxoSmithKline Consumer Healthcare LP |
| Substance Name | ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE |
| Strength Number | 254; 237.5 |
| Strength Unit | mg/5mL; mg/5mL |
| Pharmaceutical Classes |
